Reference no: EM133272192
Questions -
1. What is the primary expected outcome for a client who has preeclampsia after magnesium sulfate is administered? What are the toxic manifestations of this medication?
2. What manifestations indicate to a nurse that a client may become eclamptic?
3. Describe the condition that is a variant of gestational hypertension with hematological and hepatic manifestations.
4. For a client who has severe preeclampsia, what are the priority maternal and fetal assessments?
5. A nurse is caring for a client who has pregnancy-induced hypertension. A prescription reads: "Infuse magnesium sulfate 2 g/hr. IV. Increase to 3 g/hr. when indicated." Which of the following assessments would indicate the need for a possible increase in dose?
A. Urinary output 45 cc/hr.
B. Blood pressure remaining 124/70 mm Hg
C. Deep-tendon reflexes increase from +2 to +4
D. Client begins having regular contractions
6. Why does the umbilical cord prolapse of concern?
7. What are the emergency interventions for umbilical cord prolapse?
8. What are the criteria for diagnosis of neonatal hypoglycemia?
9. What are the assessments for neonatal hypoglycemia?
10. List five priority interventions for neonatal hypoglycemia.